CY1107346T1 - Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ - Google Patents
Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυInfo
- Publication number
- CY1107346T1 CY1107346T1 CY20081100320T CY081100320T CY1107346T1 CY 1107346 T1 CY1107346 T1 CY 1107346T1 CY 20081100320 T CY20081100320 T CY 20081100320T CY 081100320 T CY081100320 T CY 081100320T CY 1107346 T1 CY1107346 T1 CY 1107346T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- uracanic
- intercellaric
- acidise
- cis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η εφεύρεση αναφέρεται στην χρήση ενός φαρμακευτικώς αποδεκτού παράγοντα που είναι ικανός να κάνει όξινο το κυτταρόπλασμα, για την κατασκευή μιας φαρμακευτικής σύνθεσης χρήσιμης για την πρόκληση ανοσοκαταστολής σε ένα άτομο σε ένα ζώο, όπου μια αποτελεσματική ποσότητα του αναφερόμενου παράγοντα χορηγείται σε μια ουσιαστικά μη- διισταμένη μορφή στο άτομο ή στο ζώο, και όπου ο παράγοντας αναμειγνύεται με έναν φορέα ρυθμίζοντας το pΗ της σύνθεσης στο εύρος pΗ από 6.1 έως 7.0. Η εφεύρεση επίσης αφορά μια φαρμακευτική σύνθεση.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20030379A FI20030379A0 (fi) | 2003-03-14 | 2003-03-14 | Uusi farmaseuttinen koostumus |
EP04715921A EP1603559B1 (en) | 2003-03-14 | 2004-03-01 | Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107346T1 true CY1107346T1 (el) | 2012-12-19 |
Family
ID=8565804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100320T CY1107346T1 (el) | 2003-03-14 | 2008-03-21 | Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ |
Country Status (14)
Country | Link |
---|---|
US (3) | US8313738B2 (el) |
EP (2) | EP2014289A1 (el) |
JP (2) | JP5398954B2 (el) |
AT (1) | ATE386515T1 (el) |
AU (1) | AU2004218944B2 (el) |
CA (1) | CA2518885C (el) |
CY (1) | CY1107346T1 (el) |
DE (1) | DE602004011906T2 (el) |
DK (1) | DK1603559T3 (el) |
ES (1) | ES2299823T3 (el) |
FI (1) | FI20030379A0 (el) |
PL (1) | PL1603559T3 (el) |
PT (1) | PT1603559E (el) |
WO (1) | WO2004080456A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20031793A0 (fi) * | 2003-12-09 | 2003-12-09 | Lasse Leino | Uusi anti-proliferatiivinen farmaseuttinen koostumus |
JP5756615B2 (ja) * | 2010-11-02 | 2015-07-29 | 花王株式会社 | オートインデューサー−2阻害剤、並びに歯周病又は齲蝕病の予防及び/又は治療剤 |
WO2021181711A1 (ja) * | 2020-03-10 | 2021-09-16 | 均 石井 | アレルギー治療薬 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3876765A (en) * | 1968-05-03 | 1975-04-08 | Choay Sa | Pharmaceutical composition containing vitamin b' 12', process of making the same and method of treatment therewith |
JPS59139315A (ja) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | クリ−ム剤 |
DE4121030A1 (de) | 1990-06-29 | 1992-01-02 | Beiersdorf Ag | Dermatologische zusammensetzungen mit einem gehalt an cis-urocaninsaeure |
US5455036A (en) | 1990-06-29 | 1995-10-03 | Bode Chemie | Method of using cis-urocaninic acid for topically treating psoriasis |
DE4122497C2 (de) * | 1991-07-02 | 1998-03-26 | Wogepharm Gmbh | Verwendung von trans-Urokaninsäure bei der prophylaktischen Therapie der Psoriasis |
US5843979A (en) * | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
CA2114968A1 (en) * | 1993-02-25 | 1994-08-26 | John Wille | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
GB9306473D0 (en) * | 1993-03-29 | 1993-05-19 | Bioglan Lab Ltd | Pharmaceutically useful compounds |
US5686100A (en) | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
US6153176A (en) * | 1995-01-20 | 2000-11-28 | The Procter & Gamble Company | Low pH sunscreen compositions |
AU3309097A (en) * | 1996-06-12 | 1998-01-07 | Alza Corporation | Reduction of skin sensitization in electrotransport drug delivery |
US6310067B1 (en) * | 1998-02-05 | 2001-10-30 | Senju Pharmaceutical Co., Ltd. | Urocanic acid derivatives |
DE19817295A1 (de) | 1998-04-18 | 1999-10-21 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an unsymmetrisch substituiertenTriazinderivaten zum Erhalt des Urocaninsäurestatus der Haut |
US6420378B1 (en) | 1999-10-15 | 2002-07-16 | Supergen, Inc. | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
US6582734B1 (en) * | 2000-07-20 | 2003-06-24 | Ecolab Inc. | Antimicrobial composition useful for the treatment of bovine mastitis |
FI20031793A0 (fi) * | 2003-12-09 | 2003-12-09 | Lasse Leino | Uusi anti-proliferatiivinen farmaseuttinen koostumus |
-
2003
- 2003-03-14 FI FI20030379A patent/FI20030379A0/fi unknown
-
2004
- 2004-03-01 US US10/534,988 patent/US8313738B2/en not_active Expired - Fee Related
- 2004-03-01 EP EP08001152A patent/EP2014289A1/en not_active Withdrawn
- 2004-03-01 DE DE602004011906T patent/DE602004011906T2/de not_active Expired - Lifetime
- 2004-03-01 PL PL04715921T patent/PL1603559T3/pl unknown
- 2004-03-01 EP EP04715921A patent/EP1603559B1/en not_active Expired - Lifetime
- 2004-03-01 CA CA2518885A patent/CA2518885C/en not_active Expired - Fee Related
- 2004-03-01 AT AT04715921T patent/ATE386515T1/de active
- 2004-03-01 ES ES04715921T patent/ES2299823T3/es not_active Expired - Lifetime
- 2004-03-01 AU AU2004218944A patent/AU2004218944B2/en not_active Ceased
- 2004-03-01 DK DK04715921T patent/DK1603559T3/da active
- 2004-03-01 JP JP2006505614A patent/JP5398954B2/ja not_active Expired - Fee Related
- 2004-03-01 PT PT04715921T patent/PT1603559E/pt unknown
- 2004-03-01 WO PCT/FI2004/000109 patent/WO2004080456A1/en active IP Right Grant
-
2008
- 2008-03-21 CY CY20081100320T patent/CY1107346T1/el unknown
-
2010
- 2010-12-21 JP JP2010285098A patent/JP2011057708A/ja active Pending
-
2012
- 2012-08-14 US US13/584,999 patent/US8673281B2/en not_active Expired - Fee Related
- 2012-10-15 US US13/651,555 patent/US8673280B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE602004011906D1 (de) | 2008-04-03 |
PT1603559E (pt) | 2008-03-11 |
ES2299823T3 (es) | 2008-06-01 |
AU2004218944A1 (en) | 2004-09-23 |
US8673281B2 (en) | 2014-03-18 |
CA2518885A1 (en) | 2004-09-23 |
EP2014289A1 (en) | 2009-01-14 |
JP2006520369A (ja) | 2006-09-07 |
EP1603559B1 (en) | 2008-02-20 |
US20130041006A1 (en) | 2013-02-14 |
US8313738B2 (en) | 2012-11-20 |
ATE386515T1 (de) | 2008-03-15 |
FI20030379A0 (fi) | 2003-03-14 |
US20060035973A1 (en) | 2006-02-16 |
PL1603559T3 (pl) | 2008-07-31 |
EP1603559A1 (en) | 2005-12-14 |
AU2004218944B2 (en) | 2009-10-08 |
CA2518885C (en) | 2011-08-02 |
JP2011057708A (ja) | 2011-03-24 |
DK1603559T3 (da) | 2008-06-23 |
JP5398954B2 (ja) | 2014-01-29 |
WO2004080456A1 (en) | 2004-09-23 |
US8673280B2 (en) | 2014-03-18 |
US20120315299A1 (en) | 2012-12-13 |
DE602004011906T2 (de) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
DK0740650T3 (da) | Codrugs som metode til styret transport af lægemiddel | |
BR0009043A (pt) | Composto, composição farmacêutica, e, método de tratar uma doença em um animal em que a atividade da cisteìna protease contribui para a patologia e/ou sintomatologia da doença | |
UY26139A1 (es) | Composiciones de medicamentos a base de compuestos anticolinérgicamente activos y beta- miméticos | |
SE0200979D0 (sv) | New compounds | |
CY1107312T1 (el) | Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της | |
TR200200716T2 (tr) | Ketiyapin granülleri | |
PT96506A (pt) | Processo para a preparacao de composicoes orais que incorporam como ingrediente activo pimobendano | |
DE60219314D1 (de) | Halogenhaltige zusammensetzung, verfahren zu deren herstellung und deren verwendung | |
BRPI0410861A (pt) | métodos e composições para a produção de aminoácidos | |
TR200400228T4 (tr) | Psöryazinin tedavisinde kullanılacak maddeler | |
BR0210912A (pt) | Compostos e composições como inibidores de catepsina | |
CY1107346T1 (el) | Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ | |
ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
DE60030654D1 (de) | Lasofoxifen enthaltende Zusammensetzungen | |
BR0309996A (pt) | Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias | |
SE0001916D0 (sv) | Novel formulation | |
DE69635806D1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
IT1306147B1 (it) | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali | |
BRPI0407304A (pt) | Agentes antibacterianos | |
BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
BRPI0414319A (pt) | agentes antibacterianos de quinolona | |
AR008764A1 (es) | Sales hidratadas de n,n'-diacetilcistina, proceso para su preparacion, y composiciones terapeuticas que comprenden a dichas sales como ingredienteactivo. | |
FI20031793A0 (fi) | Uusi anti-proliferatiivinen farmaseuttinen koostumus | |
BR0313076A (pt) | Sal de ácido orgânico de amlodipina |